AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

Entity uei:LVEBAQTPN615 · UEI LVEBAQTPN615

About this data

Bounded ingest, not a census: 20,977 contract awards currently loaded (1,294 with full transaction history), per the scope in outlay.config.json. Totals are totals of the ingested set.
Dollar amounts are obligations — money the government has promised to pay, not cash already out the door. Agencies report this data themselves; the Defense Department publishes ~90 days late; the current budget year is still in progress. See methodology.
Source records republish silently; Outlay keeps its own append-only version archive from first pull onward. Post-publication revisions recorded so far: 0 awards (0 revisions). Revisions are routine (spending progresses, errors get corrected) and are not themselves evidence of anything.

Last ingest run #11 (failed) started Aug 5, 2026, 07:42 UTC — 0 awards, 0 details, 0 transactions.

Obligations by fiscal year

$185K

$173K


36C26024F0050 ↗ SODIUM OXYBATE (XYREM GENERIC)	Department of Veterans Affairs Department of Veterans Affairs	FY2024	Nov 1, 2023 – Oct 31, 2024	$185K	—	0
36C26025F0044 ↗ XYREM (SODIUM OXYBATE) ORAL SOLUTION.	Department of Veterans Affairs Department of Veterans Affairs	FY2025	Nov 1, 2024 – Oct 31, 2025	$173K	—	0

Raw recipient names from source records that resolved to this entity.